Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin

By Severina I.S.   Pyatakova N.V.   Bussygina O.G.   Mikhailitsyn F.S.   Khropov Y.V.  

European Journal of Pharmacology, Vol. 438, Iss. 1, 2002-03 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite

Activators of the nitric oxide sensor, soluble guanylate cyclase

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1765-1770

Informa Healthcare

Access to resources Recommend Favorite

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction

By Cellek Selim   Rees Rowland W   Kalsi Jas  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1563-1573

Informa Healthcare

Access to resources Recommend Favorite

YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice

By Teng C.-M.   Wu C.-C.   Ko F.-N.   Lee F.-Y.   Kuo S.-C.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 161-166

Elsevier

Access to resources Recommend Favorite

Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts

By Kojda G.   Kottenberg K.   Noack E.  

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 181-190

Elsevier

Access to resources Recommend Favorite